Ronald E Blaylock - Net Worth and Insider Trading
Ronald E Blaylock Net Worth
The estimated net worth of Ronald E Blaylock is at least $2 Million dollars as of 2026-08-21. Ronald E Blaylock is the Director of Pfizer Inc and owns about 71,688 shares of Pfizer Inc (PFE) stock worth over $2 Million. Ronald E Blaylock is the Director of CarMax Inc and owns about 5,854 shares of CarMax Inc (KMX) stock worth over $366,109. Ronald E Blaylock is also the Director of WR Berkley Corp and owns about 0 shares of WR Berkley Corp (WRB) stock worth over $0. Details can be seen in Ronald E Blaylock's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ronald E Blaylock has not made any transactions after 2026-08-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ronald E Blaylock
Ronald E Blaylock Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ronald E Blaylock owns 7 companies in total, including Pfizer Inc (PFE) , CarMax Inc (KMX) , and WR Berkley Corp (WRB) among others .
Click here to see the complete history of Ronald E Blaylock’s form 4 insider trades.
Insider Ownership Summary of Ronald E Blaylock
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| PFE | Pfizer Inc | 2026-08-05 | director |
| KMX | CarMax Inc | 2021-07-16 | director |
| WRB | WR Berkley Corp | 2011-04-27 | director |
| 2019-07-17 | director | ||
| 2003-08-11 | director | ||
| 2021-01-05 | director | ||
| 2003-08-11 | director |
Ronald E Blaylock Latest Holdings Summary
Ronald E Blaylock currently owns a total of 3 stocks. Among these stocks, Ronald E Blaylock owns 71,688 shares of Pfizer Inc (PFE) as of August 5, 2026, with a value of $2 Million and a weighting of 84.63%. Ronald E Blaylock owns 5,854 shares of CarMax Inc (KMX) as of July 16, 2021, with a value of $366,109 and a weighting of 15.37%. Ronald E Blaylock also owns 0 shares of WR Berkley Corp (WRB) as of April 27, 2011, with a value of $0 and a weighting of 0%.
Latest Holdings of Ronald E Blaylock
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PFE | Pfizer Inc | 2026-08-05 | 71,688 | 28.12 | 2,015,508 |
| KMX | CarMax Inc | 2021-07-16 | 5,854 | 62.54 | 366,109 |
| WRB | WR Berkley Corp | 2011-04-27 | 0 | 68.58 | 0 |
Holding Weightings of Ronald E Blaylock
Ronald E Blaylock Form 4 Trading Tracker
According to the SEC Form 4 filings, Ronald E Blaylock has made a total of 2 transactions in Pfizer Inc (PFE) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Pfizer Inc is the acquisition of 39,231 shares on August 5, 2026, which cost Ronald E Blaylock around $998,821.
According to the SEC Form 4 filings, Ronald E Blaylock has made a total of 0 transactions in CarMax Inc (KMX) over the past 5 years. The most-recent trade in CarMax Inc is the sale of 12,500 shares on July 16, 2021, which brought Ronald E Blaylock around $2 Million.
According to the SEC Form 4 filings, Ronald E Blaylock has made a total of 0 transactions in WR Berkley Corp (WRB) over the past 5 years. The most-recent trade in WR Berkley Corp is the sale of 18,562 shares on April 27, 2011, which brought Ronald E Blaylock around $176,055.
Insider Trading History of Ronald E Blaylock
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Ronald E Blaylock Trading Performance
GuruFocus tracks the stock performance after each of Ronald E Blaylock's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ronald E Blaylock is -1.16%. GuruFocus also compares Ronald E Blaylock's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ronald E Blaylock within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ronald E Blaylock's insider trading performs compared to the benchmark.
Performance of Ronald E Blaylock
Ronald E Blaylock Ownership Network
Ownership Network List of Ronald E Blaylock
Ownership Network Relation of Ronald E Blaylock

Ronald E Blaylock Owned Company Details
What does Pfizer Inc do?
Who are the key executives at Pfizer Inc?
Ronald E Blaylock is the director of Pfizer Inc. Other key executives at Pfizer Inc include Group President Albert Bourla , SVP & Controller Jennifer B. Damico , and Senior Vice President Dennis P Hancock .
Pfizer Inc (PFE) Insider Trades Summary
Over the past 18 months, Ronald E Blaylock made 1 insider transaction in Pfizer Inc (PFE) with a net purchase of 39,231. Other recent insider transactions involving Pfizer Inc (PFE) include a net sale of 7,778 shares made by Jennifer B. Damico , a net purchase of 38,000 shares made by Albert Bourla , and a net purchase of 37,632 shares made by Mortimer J Buckley .
In summary, during the past 3 months, insiders sold 5,278 shares of Pfizer Inc (PFE) in total and bought 114,863 shares, with a net purchase of 109,585 shares. During the past 18 months, 7,778 shares of Pfizer Inc (PFE) were sold and 114,863 shares were bought by its insiders, resulting in a net purchase of 107,085 shares.
Pfizer Inc (PFE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pfizer Inc Insider Transactions
Ronald E Blaylock Mailing Address
Above is the net worth, insider trading, and ownership report for Ronald E Blaylock. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Ronald E Blaylock's mailing address is: New York Ny 10001.